SNP and gene associations use P < 10⁻¹⁰. Change threshold · Counts cover features with indexed GWAS data; — means unavailable.

GeneAssociated metabolitesResearch resources

GENE DETAIL · Glycine max

Glyma.09G052700

Description hypothetical protein

Gene interval Chr09:4617652–4626364 (+), Wm82.a2.v1 · 1-based inclusive

Arabidopsis ortholog AT1G31120:KUP10:K+ uptake permease 10

Genome context

Explore gene–feature relationships using Overlap or Within ±5 kb. Scope definitions

Explore research resources ↓
Associated metabolite features1463Overlap
Maximum supporting SNP records2
Features with ≥2 supporting SNP records3

Supporting SNP records satisfy P < 10⁻¹⁰ and the selected positional scope. Counts cover the 30345 features with indexed GWAS data.

Additional descriptive statistic

Mean supporting SNP records per associated feature: 1.0021.

Research resources

Follow this gene identifier to compare annotations, examine protein function and find supporting literature.

These links search the displayed identifier. Check the organism, genome assembly and evidence in the destination record.

Compare gene models, expression and reported orthologs

SoyBase gene-name translator ↗SoyBase expression resources ↗Legume Information System ↗

Arabidopsis IDs in the supplied annotation

Use expression and ortholog evidence to develop a testable hypothesis. The linked resources do not establish the function of this soybean gene in the measured samples.

Associated metabolites

Browse associated features and open their GWAS evidence or compound candidates.

1463 matching features · page 129 of 147

Metabolite IDCandidate annotationDeionized mass (Da)Supporting SNP recordsMinimum P
P46931 No candidate annotation 670.2582 13.485e-11
P47032 Pyrocurzerenone 212.1192 11.522e-12
P47043 Oxyphenonium 347.2426 13.994e-12
P47044 No candidate annotation 97.5036 14.046e-11
P47049 2,3-Dimethylbenzofuran 146.0726 11.652e-18
P47071 Chondramide A 646.3320 11.155e-11
P47118 3b,15b,17a-Trihydroxy-pregnenone 348.2285 11.171e-15
P47172 Dibucaine 343.2279 19.026e-11
P47204 Ibritumomab tiuxetan 569.2313 11.011e-15
P47300 No candidate annotation 534.7868 16.629e-14